Cutaneous leishmaniasis as travelers' disease. Clinical presentation, diagnostics and therapy;Kutane leishmaniasis als reisedermatose: Klinik, diagnostik und therapie

Hautarzt

Volumn 63, Issue 3, 2012, Pages 233-249

  Von Stebut, E ^a   Schleicher, U ^b   Bogdan, C ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Cutaneous leishmaniasis; Leishmaniasis; Mucocutaneous leishmaniasis; Oriental sore; Therapy

Indexed keywords

ARTICLE; HUMAN; IMMUNE STATUS; LEISHMANIA; PAPULE; SKIN BIOPSY; SKIN LEISHMANIASIS; SKIN ULCER;

ANIMALS; ANTIPROTOZOAL AGENTS; BIOPSY; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, MUCOCUTANEOUS; SKIN; TRAVEL;

EID: 84863112926     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-012-2327-x     Document Type: Article

References (22)

1. Amato VS, Tuon FF, Imamura R et al (2009) Mucosal leishmaniasis: description of case management approaches and analysis of riskfactors for treatment failure in a cohort of 140 patients in Brazil. J Eur Acad Dermatol Venereol 23:1026-34
2. Boecken G, Sunderkötter C, Bogdan C et al (2011) Diagnostik und Therapie der kutanen und mukokutanen Leishmaniasis in Deutschland. J Dtsch Dermatol Ges 9(Suppl 8):1-51
3. Bogdan C, Schönian G, Banuls A-L et al (2001) Visceral leishmaniosis in a German child that had never entered a known endemic area: case report and review of the literature. Clin Infect Dis 32:302-307
4. Bogdan C (2008) Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell Microbiol 10:1221-1234 (Pubitemid 351663916)
5. Convit J (1996) Leishmaniasis: immunological and clinical aspects and vaccines in Venezuela. Clin Dermatol 14:479-487 (Pubitemid 26327741)
6. Dedet J-P, Pratlong F, Lanotte G, Ravel C (1999) The parasite. Clin Dermatol 17:261-268 (Pubitemid 29497889)
7. Gonzalez U, Pinart M, Reveiz L, Alvar J (2008) Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev CD005067
8. Gonzalez U, Pinart M, Rengifo-Pardo M et al (2009) Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev CD004834
9. Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191-1199 (Pubitemid 29460458)
10. Khamesipour A, Dowlati Y, Asilian A et al (2005) Leishmanization: use of an old method for evaluation of candidatevaccines against leishmaniasis. Vaccine 23:3642-3648 (Pubitemid 40692409)
11. Murray HW, Berman JD, Davies CR, Saravia NG (2005) Advances in leishmaniasis. Lancet 366:1561-1577 (Pubitemid 41540115)
12. Naucke TJ, Menn B, Massberg D, Lorentz S (2008) Sandflies and leishmaniasis in Germany. Parasitol Res 103(Suppl 1):65-68
13. Oliveira-Neto MP, Mattos M, Souza CS et al (1998) Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis. Int J Dermatol 37:846-849 (Pubitemid 28545279)
14. Reithinger R, Dujardin JC, Louzir H et al (2007) Cutaneous leishmaniasis. Lancet Infect Dis 7:581-596 (Pubitemid 47277438)
15. Rittig MC, Bogdan C (2000) Leishmania-host cell interaction: complexities and alternative views. Parasitol Today 16:292-297 (Pubitemid 30447394)
16. Rivas L, Moreno J, Canavate C, Alvar J (2004) Virulence and disease in leishmaniasis: What is relevant for the patient. Trends Parasitol 20:297-301 (Pubitemid 38749069)
17. Sacks DL, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2:845-858 (Pubitemid 37328707)
18. Turetz ML, Machado PR, Ko AL et al (2002) Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 186:1829-1834 (Pubitemid 35463517)
19. Stebut E von (2007) Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy. Exp Dermatol 16:340-346 (Pubitemid 46394850)
20. Woelbing F, Lopez Kostka S, Moelle K et al (2006) Uptake of Leishmania major by dendritic cells is mediated by Fcg receptors and facilitates acquisition of protective immunity. J Exp Med 203:177-188 (Pubitemid 43139656)
21. von Stebut E, Sunderkötter C (2007) Kutane Leismaniasis. Hautarzt 58:445-459
22. Asilian A, Davami M (2006) Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol 31(5):634-637 (Pubitemid 44086787)